Company intelligence / Profile preview

ChairsideSplint

Port St. Lucie, Florida, United Stateschairsidesplintstore.com ↗

Ownership: Private
Development stage: Commercial

Overview

ChairsideSplint, through its exclusive commerce site ChairsideSplintStore.com, markets the FDA-cleared NTI family of devices for migraine and bruxism management. The devices are widely used in dental practices for non-pharmacological prevention of migraines and tension headaches. Clinical studies have shown significant reduction in clenching forces (~70%) and migraine frequency (~77% reduction in events among users). The company is active internationally with a focus on digital dentistry solutions.

Therapeutic areas: Neurology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Glidewell Dental is a key distribution/manufacturing partner for the NTI-tss Plus device.

Beyond the preview

Go deeper on ChairsideSplint.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChairsideSplint.

Explore the full profile